Header Logo

Connection

Deepika Neelakantan to Neoplasm Recurrence, Local

Back to Details
This is a "connection" page, showing publications Deepika Neelakantan has written about Neoplasm Recurrence, Local.
Deepika Neelakantan
Connection Strength
0.195
Neoplasm Recurrence, Local
  1. Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary. Gynecol Oncol. 2025 Dec; 203:158-164.
    View in: PubMed
    Score: 0.195
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.